Summary
Machine-generated summaryUniwersytecki Szpital Kliniczny Nr 1 w Lublinie awarded a contract for the supply of medicinal products used in drug programmes. The procurement was divided into 39 parts and partial offers were allowed; bidders could offer for any number of parts. The listed products include brentuximab vedotin, bimekizumab, brolucizumab, certolizumab pegol, secukinumab, elotuzumab, sofosbuvir plus velpatasvir, nivolumab, eltrombopag, dabrafenib, ixekizumab and bexarotene. The winners were Takeda Pharma Sp. z o.o., Urtica sp. z o. o. and Farmacol Logistyka Sp. z o.o. The contract was awarded on 2026-05-18 for EUR 3,442,828.09.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 6 days ago
More from this buyer
Full buyer profile13 open tenders right now
- Dostawa wyposażenia medycznego na potrzeby Centrum Diagnostyki i Leczenia Chorób Nowotworowych Skóry w ramach Programu Interreg NEXT Polska - Ukraina 2021-2027 - powtórzenie 7 days left
- Dostawa systemu zarządzającego trybami obsługi pacjenta w Szpitalnym Oddziale Ratunkowym (TOPSOR) wraz z systemem segregacji medycznej, dostawą kardiomonitorów oraz integracją z HIS 7 days left
- Dostawa druków i kopert dla jednostek USK 1 w Lublinie. 7 days left
Recent awards
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,443,725
- Buyer track record on Aperlena
- 378 notices tracked · 179 awarded
- €829,920,245 in awarded contracts
Never miss a tender like this
910 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alert